Key result
Warfarin use in haemodialysis patients with atrial fibrillation lacks randomized efficacy data and increases the risk of haemorrhagic stroke and major bleeding.
Why the study?
Does warfarin prevent stroke in haemodialysis patients with atrial fibrillation?
Population
Patients on haemodialysis with atrial fibrillation
Design
Review
Authors
Loading...
Avoids routine warfarin in haemodialysis AF without proven benefit; leaves open net clinical value pending RCTs.
Does warfarin prevent stroke in haemodialysis patients with atrial fibrillation?
Routine use of warfarin in dialysis patients with atrial fibrillation should be discouraged due to increased bleeding risks and lack of proven efficacy.
Yang et al. (2010) conducted a review in Atrial fibrillation in haemodialysis patients. Warfarin was evaluated. Warfarin use in haemodialysis patients with atrial fibrillation lacks randomized efficacy data and increases the risk of haemorrhagic stroke and major bleeding.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: